Table of Contents Author Guidelines Submit a Manuscript
Interdisciplinary Perspectives on Infectious Diseases
Volume 2009, Article ID 137609, 7 pages
http://dx.doi.org/10.1155/2009/137609
Research Article

Procalcitonin as a Biomarker for a Bacterial Infection on Hospital Admission: A Critical Appraisal in a Cohort of Travellers with Fever after a Stay in (Sub)tropics

1Department of Internal Medicine, Harbour Hospital, Institute for Tropical Diseases, Haringvliet 2, 3011 TD Rotterdam, The Netherlands
2Department of Internal Medicine, Erasmus Medical Centre, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands
3Department of Microbiology, Vlietland Hospital, P.O. Box 215, 3100 AE Schiedam, The Netherlands

Received 22 June 2009; Accepted 8 September 2009

Academic Editor: Ann Moormann

Copyright © 2009 Dennis A. Hesselink et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Bottieau, J. Clerinx, E. Van den Enden et al., “Fever after a stay in the tropics: diagnostic predictors of the leading tropical conditions,” Medicine, vol. 86, no. 1, pp. 18–25, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. V. Nobre, S. Harbarth, J.-D. Graf, P. Rohner, and J. Pugin, “Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial,” American Journal of Respiratory and Critical Care Medicine, vol. 177, no. 5, pp. 498–505, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Linscheid, D. Seboek, E. S. Nylen et al., “In vitro and in vivo calcitonin I gene expression in parenchymal cells: a novel product of human adipose tissue,” Endocrinology, vol. 144, no. 12, pp. 5578–5584, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Christ-Crain, D. Jaccard-Stolz, R. Bingisser et al., “Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial,” The Lancet, vol. 363, no. 9409, pp. 600–607, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Christ-Crain, D. Stolz, R. Bingisser et al., “Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial,” American Journal of Respiratory and Critical Care Medicine, vol. 174, no. 1, pp. 84–93, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. D. Stolz, M. Christ-Grain, R. Bingisser et al., “Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy,” Chest, vol. 131, no. 1, pp. 9–19, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. Brahms PCT International, January 2009, http://www.procalcitonin.com.
  8. M. Meisner, F.-M. Brunkhorst, H.-B. Reith, J. Schmidt, H.-G. Lestin, and K. Reinhart, “Clinical experiences with a new semi-quantitative solid phase immunoassay for rapid measurement of procalcitonin,” Clinical Chemistry and Laboratory Medicine, vol. 38, no. 10, pp. 989–995, 2000. View at Google Scholar · View at Scopus
  9. A. E. Jones, J. F. Fiechtl, M. D. Brown, J. J. Ballew, and J. A. Kline, “Procalcitonin test in the diagnosis of bacteremia: a meta-analysis,” Annals of Emergency Medicine, vol. 50, no. 1, pp. 34–41, 2007. View at Publisher · View at Google Scholar · View at Scopus